Company Overview

Avricore Health Inc. is a Canadian health technology company focused on advancing preventive healthcare through point-of-care diagnostics delivered in community pharmacy settings. The company operates at the intersection of healthcare services, medical diagnostics, and health data analytics, with a core emphasis on early disease detection and chronic disease management. Its primary revenue driver is the deployment of in-pharmacy diagnostic testing platforms that generate clinical data for patients, pharmacists, and healthcare systems.

The company’s flagship business is built around its HealthTab™ platform, which enables pharmacists to administer blood-based tests and provide real-time results and reports. Avricore Health primarily serves retail pharmacy chains, independent pharmacies, and their patient populations, positioning itself as an enabler of decentralized, accessible healthcare. The company was founded in Canada and has evolved from a technology-focused startup into a publicly listed healthcare diagnostics provider, expanding its scope alongside increasing recognition of pharmacies as frontline healthcare access points.

Business Operations

Avricore Health operates through a single integrated operating segment centered on pharmacy-based diagnostics, with HealthTab™ functioning as its core business unit and technology platform. Revenue is generated through testing services, platform usage fees, and related data and reporting services provided to pharmacy partners. The company’s model leverages existing pharmacy infrastructure, allowing scalable deployment without the need for Avricore to own or operate clinical facilities directly.

Operations are primarily domestic within Canada, where the company collaborates with national and regional pharmacy chains. The company controls proprietary software, diagnostic workflows, and data reporting systems that support regulatory-compliant testing and results delivery. HealthTab™ is a wholly owned subsidiary and represents Avricore’s principal operating asset. Public disclosures indicate no material joint ventures; any additional partnerships or technology acquisitions beyond HealthTab have limited publicly verifiable detail, and data is inconclusive based on available public sources.

Strategic Position & Investments

Avricore Health’s strategy centers on scaling preventive diagnostics through pharmacies and expanding test menus that address cardiometabolic risk, chronic disease monitoring, and population health screening. Growth initiatives focus on increasing pharmacy adoption, deepening relationships with large pharmacy networks, and enhancing data analytics capabilities tied to longitudinal patient health insights.

The company has evaluated and pursued complementary technologies aligned with decentralized diagnostics and digital health. While Avricore has announced past technology-related transactions and evaluations, details regarding the long-term financial impact or integration of certain acquired or licensed technologies remain limited in public filings. As such, beyond HealthTab™, information on additional notable subsidiaries or material portfolio investments is inconclusive based on available public sources.

Geographic Footprint

Avricore Health is headquartered in Canada, with its operational and commercial footprint primarily concentrated across Canadian provinces. Its diagnostic services are delivered through participating pharmacies nationwide, giving the company broad domestic market exposure without maintaining a large physical footprint.

Internationally, Avricore Health has indicated interest in expanding the HealthTab™ model into additional markets where pharmacy-led care is supported by regulation and payer systems. However, as of the most recent publicly available disclosures, the company does not report material recurring revenue from outside Canada, and its international operational influence remains limited.

Leadership & Governance

Avricore Health is led by an executive team with backgrounds in financial services, healthcare, and technology, reflecting the company’s focus on regulated health innovation and scalable commercial models. Leadership emphasizes preventive care, data-driven decision-making, and the integration of diagnostics into everyday healthcare access points.

Key executives include:

• Sherry Porter – Chief Executive Officer
• Angela Crabtree – Chief Financial Officer

Public filings identify additional senior management and board members; however, detailed role definitions and executive responsibilities beyond the CEO and CFO are not consistently disclosed across available public sources, and further specifics are inconclusive based on available public sources.